Respiratory Muscle Structure and Function in Mechanically Ventilated Patients and Long-term Outcomes
RESPIRE
1 other identifier
observational
230
1 country
1
Brief Summary
Air is normally pumped in and out of the lungs by the muscles that contribute to inhalation and exhalation, called the respiratory muscles. The abdominal muscles help by forcing air out of your lungs during exhalation; whereas the diaphragm, the main muscle used for breathing, contracts to get air into the lungs during inhalation. With mechanical ventilation, respiratory muscles are able to rest and recover while the breathing machine takes over; however, this may cause respiratory muscle weakness. Patients who develop weakness of these muscles may require more assistance from the ventilator and take longer to recover their ability to breathe without assistance. The impact of this phenomenon on long-term outcomes is uncertain. The RESPIRE study is designed to characterize how respiratory muscles change during mechanical ventilation and to evaluate the impact on long term quality of life. An additional objective of this study is to examine novel measures obtained from automated functions of a ventilator, that may better predict success from weaning from mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2023
CompletedStudy Start
First participant enrolled
April 27, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMay 21, 2024
May 1, 2024
2.7 years
March 2, 2023
May 18, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of life at home
5-level EQ-5D (EQ-5D-5L) score - The EQ-5D-5L is a validated self-reported instrument assessing quality of life at the moment questionnaire is completed. Each question is scored from 1 (no problems) to 5 (inability to perform activity) and are independently assessed.
Day 180
Quality of life at home
Montreal Cognitive Assessment (MOCA) score - MoCA is a clinician-reported measure to assess for cognitive impairments. MoCA is scored out of 30 with scores \<26 indicating cognitive impairment.
Day 180
Secondary Outcomes (10)
Duration of ventilation
Until hospital discharge (up to 6 months)
Muscle research council score
Until day 14
Airway occlusion pressure (P0.1)
First spontaneous breathing trial (within 5 minutes of onset)
Expiratory occlusion pressure (Pocc)
First spontaneous breathing trial (within 5 minutes of onset)
Maximal inspiratory pressure (MIP)
First spontaneous breathing trial within 30 minutes of onset
- +5 more secondary outcomes
Study Arms (3)
Cases
Adult patients ≥18 years of age undergoing invasive mechanical ventilation in the ICU for any reason within 36 hours of intubation
Control condition A
Non-invasively ventilated patients in the ICU within 36 hours of initiating non-invasive ventilation
Control condition B
Non-ventilated patients admitted to the ICU receiving no respiratory support or oxygen therapy alone, including high flow nasal cannula
Interventions
Diaphragm thickness, diaphragm tidal thickening fraction, abdominal muscle thickness, rectus femoris cross-sectional area, maximal diaphragm thickening fraction, abdominal muscle thickening fraction
Airway occlusion pressure, maximal inspiratory pressure, muscle research council score
Eligibility Criteria
Patients will be enrolled in the Medical-Surgical ICU at Toronto General Hospital.
You may qualify if:
- Adult patients ≥18 years of age undergoing invasive mechanical ventilation in the ICU for any reason within 36 hours of intubation
- Non-invasively ventilated patients in the ICU within 36 hours of initiating non-invasive ventilation
- Non-ventilated patients admitted to the ICU receiving no respiratory support or oxygen therapy alone, including high flow nasal cannula
You may not qualify if:
- Patients expected to be extubated within 24 hours of screening for eligibility
- Patients who have already undergone a SBT at time of screening
- Patients with a previously diagnosed neuromuscular disorder
- Patients receiving long-term invasive mechanical ventilation (prior to current hospitalization)
- Patients who have required previously (during current hospitalization) a period of invasive ventilation in ICU of more than 24 hours
- Patients who have previously been enrolled in the study
- Patients for whom post-hospital follow-up may be challenging, e.g. those who reside overseas or who have no fixed address
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Biospecimen
Skeletal Troponin-I
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ewan Goligher, MD, PhD
University Health Network, Toronto
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2023
First Posted
May 15, 2023
Study Start
April 27, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
May 21, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share